Advanced Endoscopic Resections for Rectal Neoplasms

Starting soon

Conditions studied: Rectal Cancer, Rectal Adenocarcinoma, Rectal Adenoma, Rectal Neuroendocrine Neoplasm, Recurrent Rectal Adenocarcinoma

In brief

This study evaluates how advanced endoscopic resection techniques affect treatment outcomes in adults with rectal cancer. Rectal cancer has traditionally been treated with standard abdominal surgery. Newer endoscopic techniques allow removal of selected early tumors and may reduce treatment-related complications. However, their effectiveness and safety in tumors with deeper invasion are not yet fully established. This multicenter retrospective observational study uses existing medical records from adults who underwent endoscopic or surgical resection of rectal tumors between 2015 and 2025. Researchers will analyze anonymized information on procedures performed and treatment outcomes to assess the safety and effectiveness of advanced endoscopic approaches. The results of this study may help guide treatment selection and improve care for people with rectal cancer.

Key facts

Study ID

NCT07410767

Run by

Jagiellonian University

People needed

300

Starts

2026-03-01

Expected to finish

2026-04-30

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with rectal neoplasms treated by advanced endoscopic resection

You may not qualify if…

• hybrid resection performed
• full-thickness resection performed
• essential procedural or outcome data were unavailable

Where it is running

• Jagiellonian University in Krakow — Krakow, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.